Bray F, Laversanne M, Sung H et al (2024) Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 74:229–263. https://doi.org/10.3322/caac.21834

Article  PubMed  Google Scholar 

Kitagawa Y, Ishihara R, Ishikawa H et al (2023) Esophageal cancer practice guidelines 2022 edited by the Japan esophageal society: part 1. Esophagus 20:343–372. https://doi.org/10.1007/s10388-023-00993-2

Article  PubMed  PubMed Central  Google Scholar 

Ishihara R, Arima M, Iizuka T et al (2020) Endoscopic submucosal dissection/endoscopic mucosal resection guidelines for esophageal cancer. Dig Endosc 32:452–493. https://doi.org/10.1111/den.13654

Article  PubMed  Google Scholar 

Pimentel-Nunes P, Dinis-Ribeiro M, Ponchon T et al (2015) Endoscopic submucosal dissection: European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy 47:829–854. https://doi.org/10.1055/s-0034-1392882

Article  PubMed  Google Scholar 

Kitagawa Y, Ishihara R, Ishikawa H et al (2023) Esophageal cancer practice guidelines 2022 edited by the Japan Esophageal Society: part 2. Esophagus 20:373–389. https://doi.org/10.1007/s10388-023-00994-1

Article  PubMed  PubMed Central  Google Scholar 

Minashi K, Nihei K, Mizusawa J et al (2019) Efficacy of Endoscopic Resection and Selective Chemoradiotherapy for Stage I Esophageal Squamous Cell Carcinoma. Gastroenterology 157:382–90e3. https://doi.org/10.1053/j.gastro.2019.04.017

Article  PubMed  Google Scholar 

Nihei K, Minashi K, Yano T et al (2023) Final Analysis of Diagnostic Endoscopic Resection Followed by Selective Chemoradiotherapy for Stage I Esophageal Cancer: JCOG0508. Gastroenterology 164:296–9e2. https://doi.org/10.1053/j.gastro.2022.10.002

Article  CAS  PubMed  Google Scholar 

Yamamoto Y, Ishihara R, Kawakubo H et al (2025) Comparison of outcomes between surgery and chemoradiotherapy after endoscopic resection for pT1a-MM with lymphovascular invasion or pT1b esophageal squamous cell carcinoma: Japanese multicenter propensity score-matched study. J Gastroenterol 60:43–54. https://doi.org/10.1007/s00535-024-02188-7

Article  PubMed  Google Scholar 

Sakata Y, Ohtsu A, Horikoshi N et al (1998) Late phase II study of novel oral fluoropyrimidine anticancer drug S-1 (1 M tegafur-0.4 M gimestat-1 M otastat potassium) in advanced gastric cancer patients. Eur J Cancer 34:1715–1720. https://doi.org/10.1016/s0959-8049(98)00211-1

Article  CAS  PubMed  Google Scholar 

Koizumi W, Kurihara M, Nakano S et al (2000) Phase II study of S-1, a novel oral derivative of 5-fluorouracil, in advanced gastric cancer. For the S-1 Cooperative Gastric Cancer Study Group. Oncology 58:191–197. https://doi.org/10.1159/000012099

Article  CAS  PubMed  Google Scholar 

Shirao K, Ohtsu A, Takada H et al (2004) Phase II study of oral S-1 for treatment of metastatic colorectal carcinoma. Cancer 100:2355–2361. https://doi.org/10.1002/cncr.20277

Article  CAS  PubMed  Google Scholar 

Jeung HC, Rha SY, Cho BC et al (2006) A phase II trial of S-1 monotherapy in metastatic colorectal cancer after failure of irinotecan- and oxaliplatin-containing regimens. Br J Cancer 95:1637–1641. https://doi.org/10.1038/sj.bjc.6603468

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ueno H, Ioka T, Ikeda M et al (2013) Randomized phase III study of gemcitabine plus S-1, S-1 alone, or gemcitabine alone in patients with locally advanced and metastatic pancreatic cancer in Japan and Taiwan: GEST study. J Clin Oncol 31:1640–1648. https://doi.org/10.1200/JCO.2012.43.3680

Article  CAS  PubMed  Google Scholar 

Fukushima M (2010) Gimeracil, a component of S-1, may enhance the antitumor activity of X-ray irradiation in human cancer xenograft models in vivo. Oncol Rep. https://doi.org/10.3892/or_00000987

Article  PubMed  Google Scholar 

Ichinose Y, Seto T, Sasaki T et al (2011) S-1 plus cisplatin with concurrent radiotherapy for locally advanced non-small cell lung cancer: a multi-institutional phase II trial (West Japan Thoracic Oncology Group 3706). J Thorac Oncol 6:2069–2075. https://doi.org/10.1097/JTO.0b013e3182307e5a

Article  PubMed  Google Scholar 

Tahara M, Kiyota N, Mizusawa J et al (2015) Phase II trial of chemoradiotherapy with S-1 plus cisplatin for unresectable locally advanced head and neck cancer (JCOG0706). Cancer Sci 106:726–733. https://doi.org/10.1111/cas.12657

Article  CAS  PubMed  PubMed Central  Google Scholar 

Inoue H, Endo M, Takeshita K et al (1992) A new simplified technique of endoscopic esophageal mucosal resection using a cap-fitted panendoscope (EMRC). Surg Endosc 6:264–265. https://doi.org/10.1007/bf02498820

Article  CAS  PubMed  Google Scholar 

Onozawa M, Nihei K, Ishikura S et al (2009) Elective nodal irradiation (ENI) in definitive chemoradiotherapy (CRT) for squamous cell carcinoma of the thoracic esophagus. Radiother Oncol 92:266–269. https://doi.org/10.1016/j.radonc.2008.09.025

Article  CAS  PubMed  Google Scholar 

Kato K, Muro K, Minashi K et al (2011) Phase II study of chemoradiotherapy with 5-fluorouracil and cisplatin for Stage II-III esophageal squamous cell carcinoma: JCOG trial (JCOG 9906). Int J Radiat Oncol Biol Phys 81:684–690. https://doi.org/10.1016/j.ijrobp.2010.06.033

Article  CAS  PubMed  Google Scholar 

Igaki H, Kato H, Tachimori Y et al (2001) Prognostic evaluation for squamous cell carcinomas of the lower thoracic esophagus treated with three-field lymph node dissection. Eur J Cardiothorac Surg 19:887–893. https://doi.org/10.1016/s1010-7940(01)00701-1

Article  CAS  PubMed  Google Scholar 

Ozawa S, Tachimori Y, Baba H et al (2012) Comprehensive Registry of Esophageal Cancer in Japan, 2004. Esophagus 9:75–98. https://doi.org/10.1007/s10388-012-0327-7

Article  Google Scholar 

Kato H, Sato A, Fukuda H et al (2009) A phase II trial of chemoradiotherapy for stage I esophageal squamous cell carcinoma: Japan Clinical Oncology Group Study (JCOG9708). Jpn J Clin Oncol 39:638–643. https://doi.org/10.1093/jjco/hyp069

Article  PubMed  Google Scholar 

Torres-Saavedra PA, Winter KA (2022) An Overview of Phase 2 Clinical Trial Designs. Int J Radiat Oncol Biol Phys 112:22–29. https://doi.org/10.1016/j.ijrobp.2021.07.1700

Article  PubMed  Google Scholar 

Kanda Y (2013) Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics. Bone Marrow Transpl 48:452–458. https://doi.org/10.1038/bmt.2012.244

Article  CAS  Google Scholar 

Kato K, Ito Y, Nozaki I et al (2021) Parallel-Group Controlled Trial of Surgery Versus Chemoradiotherapy in Patients With Stage I Esophageal Squamous Cell Carcinoma. Gastroenterology 161:1878–86e2. https://doi.org/10.1053/j.gastro.2021.08.007

Article  CAS  PubMed  Google Scholar 

Ajani JA, Abramov M, Bondarenko I et al (2017) A phase III trial comparing oral S-1/cisplatin and intravenous 5-fluorouracil/cisplatin in patients with untreated diffuse gastric cancer. Ann Oncol 28:2142–2148. https://doi.org/10.1093/annonc/mdx275

Article  CAS  PubMed  Google Scholar 

Ye J, Chen J, Ge L et al (2014) Effectiveness and safety of s-1-based therapy compared with 5-Fluorouracil-based therapy for advanced colorectal cancer: a meta-analysis. Gastroenterol Res Pract 2014:146530. https://doi.org/10.1155/2014/146530

Article  PubMed  PubMed Central  Google Scholar